VITALHUB CORP (VHI.CA) Stock Fundamental Analysis
Canada - Toronto Stock Exchange - TSX:VHI - CA92847V5018 - Common Stock
9.36 CAD
+0.17 (+1.85%)
Overall VHI gets a fundamental rating of 6 out of 10. We evaluated VHI against 8 industry peers in the Health Care Technology industry. VHI has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. VHI is not priced too expensively while it is growing strongly. Keep and eye on this one! This makes VHI very considerable for growth and quality investing!
1. Profitability
1.1 Basic Checks
In the past year VHI was profitable.
VHI had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: VHI reported negative net income in multiple years.
VHI had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
VHI has a better Return On Assets (0.76%) than 100.00% of its industry peers.
The Return On Equity of VHI (1.08%) is better than 100.00% of its industry peers.
VHI has a better Return On Invested Capital (2.86%) than 100.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for VHI is in line with the industry average of 2.86%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.76% | ||
| ROE | 1.08% | ||
| ROIC | 2.86% |
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 2.88%, VHI belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
VHI's Operating Margin of 12.47% is amongst the best of the industry. VHI outperforms 100.00% of its industry peers.
VHI's Operating Margin has improved in the last couple of years.
VHI has a better Gross Margin (80.92%) than 100.00% of its industry peers.
VHI's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.47% | ||
| PM (TTM) | 2.88% | ||
| GM | 80.92% |
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
2. Health
2.1 Basic Checks
VHI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
VHI has more shares outstanding than it did 1 year ago.
The number of shares outstanding for VHI has been increased compared to 5 years ago.
VHI has a better debt/assets ratio than last year.
2.2 Solvency
VHI has an Altman-Z score of 3.92. This indicates that VHI is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.92, VHI is in the better half of the industry, outperforming 62.50% of the companies in the same industry.
VHI has a debt to FCF ratio of 0.13. This is a very positive value and a sign of high solvency as it would only need 0.13 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.13, VHI belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
A Debt/Equity ratio of 0.00 indicates that VHI is not too dependend on debt financing.
VHI has a better Debt to Equity ratio (0.00) than 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.13 | ||
| Altman-Z | 3.92 |
ROIC/WACC0.32
WACC8.83%
2.3 Liquidity
VHI has a Current Ratio of 1.94. This is a normal value and indicates that VHI is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of VHI (1.94) is better than 87.50% of its industry peers.
A Quick Ratio of 1.94 indicates that VHI should not have too much problems paying its short term obligations.
VHI has a better Quick ratio (1.94) than 87.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.94 | ||
| Quick Ratio | 1.94 |
3. Growth
3.1 Past
VHI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -14.29%.
Looking at the last year, VHI shows a very strong growth in Revenue. The Revenue has grown by 59.34%.
Measured over the past years, VHI shows a very strong growth in Revenue. The Revenue has been growing by 46.32% on average per year.
EPS 1Y (TTM)-14.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.33%
Revenue 1Y (TTM)59.34%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%94.1%
3.2 Future
Based on estimates for the next years, VHI will show a very strong growth in Earnings Per Share. The EPS will grow by 82.03% on average per year.
The Revenue is expected to grow by 27.30% on average over the next years. This is a very strong growth
EPS Next Y68.34%
EPS Next 2Y107.36%
EPS Next 3Y82.03%
EPS Next 5YN/A
Revenue Next Year53.3%
Revenue Next 2Y36.21%
Revenue Next 3Y27.3%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 156.00 indicates a quite expensive valuation of VHI.
Compared to the rest of the industry, the Price/Earnings ratio of VHI indicates a rather cheap valuation: VHI is cheaper than 100.00% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of VHI to the average of the S&P500 Index (26.37), we can say VHI is valued expensively.
A Price/Forward Earnings ratio of 31.10 indicates a quite expensive valuation of VHI.
VHI's Price/Forward Earnings ratio is rather cheap when compared to the industry. VHI is cheaper than 87.50% of the companies in the same industry.
VHI's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 36.20.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 156 | ||
| Fwd PE | 31.1 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of VHI indicates a rather cheap valuation: VHI is cheaper than 100.00% of the companies listed in the same industry.
VHI's Price/Free Cash Flow ratio is rather cheap when compared to the industry. VHI is cheaper than 87.50% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 48.49 | ||
| EV/EBITDA | 21.47 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates VHI does not grow enough to justify the current Price/Earnings ratio.
VHI has a very decent profitability rating, which may justify a higher PE ratio.
VHI's earnings are expected to grow with 82.03% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.28
PEG (5Y)N/A
EPS Next 2Y107.36%
EPS Next 3Y82.03%
5. Dividend
5.1 Amount
VHI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:VHI (12/3/2025, 7:00:00 PM)
9.36
+0.17 (+1.85%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners28.48%
Inst Owner ChangeN/A
Ins Owners11.46%
Ins Owner ChangeN/A
Market Cap590.80M
Revenue(TTM)98.17M
Net Income(TTM)2.83M
Analysts81.33
Price Target15.51 (65.71%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-78.71%
Min EPS beat(2)-129.12%
Max EPS beat(2)-28.31%
EPS beat(4)0
Avg EPS beat(4)-61.43%
Min EPS beat(4)-129.12%
Max EPS beat(4)-28.31%
EPS beat(8)0
Avg EPS beat(8)-58.34%
EPS beat(12)1
Avg EPS beat(12)-46.79%
EPS beat(16)2
Avg EPS beat(16)-54.73%
Revenue beat(2)2
Avg Revenue beat(2)9.95%
Min Revenue beat(2)7.24%
Max Revenue beat(2)12.66%
Revenue beat(4)4
Avg Revenue beat(4)6.3%
Min Revenue beat(4)0.61%
Max Revenue beat(4)12.66%
Revenue beat(8)6
Avg Revenue beat(8)4.15%
Revenue beat(12)10
Avg Revenue beat(12)4.05%
Revenue beat(16)12
Avg Revenue beat(16)4.16%
PT rev (1m)-1.75%
PT rev (3m)-2.08%
EPS NQ rev (1m)-13.45%
EPS NQ rev (3m)-11.91%
EPS NY rev (1m)0.36%
EPS NY rev (3m)-12.77%
Revenue NQ rev (1m)3.96%
Revenue NQ rev (3m)4.75%
Revenue NY rev (1m)-0.15%
Revenue NY rev (3m)3.09%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 156 | ||
| Fwd PE | 31.1 | ||
| P/S | 6.02 | ||
| P/FCF | 48.49 | ||
| P/OCF | 45.73 | ||
| P/B | 2.26 | ||
| P/tB | 12 | ||
| EV/EBITDA | 21.47 |
EPS(TTM)0.06
EY0.64%
EPS(NY)0.3
Fwd EY3.22%
FCF(TTM)0.19
FCFY2.06%
OCF(TTM)0.2
OCFY2.19%
SpS1.56
BVpS4.15
TBVpS0.78
PEG (NY)2.28
PEG (5Y)N/A
Graham Number2.37
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.76% | ||
| ROE | 1.08% | ||
| ROCE | 4.19% | ||
| ROIC | 2.86% | ||
| ROICexc | 4.95% | ||
| ROICexgc | N/A | ||
| OM | 12.47% | ||
| PM (TTM) | 2.88% | ||
| GM | 80.92% | ||
| FCFM | 12.41% |
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
ROICexc(3y)5.88%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)5.82%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y132.1%
ROICexc growth 5YN/A
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
F-Score3
Asset Turnover0.27
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.13 | ||
| Debt/EBITDA | 0.05 | ||
| Cap/Depr | 7.67% | ||
| Cap/Sales | 0.75% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 59.17% | ||
| Profit Quality | 430.43% | ||
| Current Ratio | 1.94 | ||
| Quick Ratio | 1.94 | ||
| Altman-Z | 3.92 |
F-Score3
WACC8.83%
ROIC/WACC0.32
Cap/Depr(3y)9.42%
Cap/Depr(5y)8.61%
Cap/Sales(3y)0.86%
Cap/Sales(5y)0.89%
Profit Quality(3y)466.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.33%
EPS Next Y68.34%
EPS Next 2Y107.36%
EPS Next 3Y82.03%
EPS Next 5YN/A
Revenue 1Y (TTM)59.34%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%94.1%
Revenue Next Year53.3%
Revenue Next 2Y36.21%
Revenue Next 3Y27.3%
Revenue Next 5YN/A
EBIT growth 1Y46.83%
EBIT growth 3Y217.15%
EBIT growth 5YN/A
EBIT Next Year69.12%
EBIT Next 3Y40.69%
EBIT Next 5YN/A
FCF growth 1Y-12.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-10.32%
OCF growth 3YN/A
OCF growth 5YN/A
VITALHUB CORP / VHI.CA FAQ
What is the fundamental rating for VHI stock?
ChartMill assigns a fundamental rating of 6 / 10 to VHI.CA.
Can you provide the valuation status for VITALHUB CORP?
ChartMill assigns a valuation rating of 6 / 10 to VITALHUB CORP (VHI.CA). This can be considered as Fairly Valued.
Can you provide the profitability details for VITALHUB CORP?
VITALHUB CORP (VHI.CA) has a profitability rating of 7 / 10.
What are the PE and PB ratios of VITALHUB CORP (VHI.CA) stock?
The Price/Earnings (PE) ratio for VITALHUB CORP (VHI.CA) is 156 and the Price/Book (PB) ratio is 2.26.